Megan Bradley
Family · Des Moines, IANPI 1649658014
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 59.4% of the total. Reporting peaked in 2021 at $1,984 and has fallen 97.2% since, to $55 in 2025. Among family clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $45.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- AbbVie$526
- Wardlow Enterprises$318
- Boston Scientific$55
- Averitas Pharma Inc.$40
- Abbott$24
- plus $72 from 4 others
What the payments were for
- Travel & lodging$59823%
- Food & beverage$75129%
- Education$1,20047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,515 |
| AbbVie(2 entities) | 41 | $526 |
| Wardlow Enterprises | 1 | $318 |
| Boston Scientific | 2 | $55 |
| Averitas Pharma Inc. | 2 | $40 |
| Abbott | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $13 |
How this compares
$2,549 in reported general payments places this provider in the 90th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $5,278 |
| Pregabalin | 37 | $1,266 |
| Morphine Sulfate ErMorphine Sulfate | 43 | $1,028 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $715 |
| Gabapentin | 36 | $708 |
| Oxycodone Hcl | 17 | $455 |
| Cyclobenzaprine Hcl | 30 | $195 |
| Tizanidine Hcl | 31 | $169 |
| Methylprednisolone | 16 | $137 |
Paid to pharmacies, not to this prescriber.
Other family in Des Moines
- Rodney ClarkDes Moines$63K
- Jackie ShipleyDes Moines$9K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.